Cargando…
Mefunidone Attenuates Tubulointerstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction
BACKGROUND: Inflammation has a crucial role in renal interstitial fibrosis, which is the common pathway of chronic kidney diseases. Mefunidone (MFD) is a new compound which could effectively inhibit the proliferation of renal fibroblasts in vitro. However, the overall effect of Mefunidone in renal f...
Autores principales: | Liu, Chunyan, Mei, Wenjuan, Tang, Juan, Yuan, Qiongjing, Huang, Ling, Lu, Miaomiao, Wu, Lin, Peng, Zhangzhe, Meng, Jie, Yang, Huixiang, Shen, Hong, Lv, Ben, Hu, Gaoyun, Tao, Lijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456380/ https://www.ncbi.nlm.nih.gov/pubmed/26042668 http://dx.doi.org/10.1371/journal.pone.0129283 |
Ejemplares similares
-
Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Han, Yuanyuan, et al.
Publicado: (2021) -
L-carnitine treatment attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction
por: Zhao, Hai Yan, et al.
Publicado: (2021) -
Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury
por: Li, Jiajia, et al.
Publicado: (2022) -
Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury
por: Li, Jiajia, et al.
Publicado: (2023) -
Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis
por: Chen, Lin, et al.
Publicado: (2019)